DiamiR Biosciences Expands Management Team with the Appointment of Fred Knechtel as its Chief Financial Officer
NEW HAVEN, Conn. and MONMOUTH JUNCTION, N.J., Aug. 30, 2022 /PRNewswire/ — DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced the expansion of its management team by the appointment of Fred Knechtel as Chief Financial…
Comments Off on DiamiR Biosciences Expands Management Team with the Appointment of Fred Knechtel as its Chief Financial Officer